1. Home
  2. HBCP vs ARMP Comparison

HBCP vs ARMP Comparison

Compare HBCP & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Home Bancorp Inc.

HBCP

Home Bancorp Inc.

HOLD

Current Price

$60.88

Market Cap

453.4M

Sector

Finance

ML Signal

HOLD

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$8.27

Market Cap

383.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBCP
ARMP
Founded
1908
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
453.4M
383.7M
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
HBCP
ARMP
Price
$60.88
$8.27
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$63.50
$15.00
AVG Volume (30 Days)
81.5K
40.8K
Earning Date
04-20-2026
05-13-2026
Dividend Yield
2.08%
N/A
EPS Growth
29.01
53.40
EPS
5.87
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.74
N/A
P/E Ratio
$10.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$40.10
$0.90
52 Week High
$64.17
$13.75

Technical Indicators

Market Signals
Indicator
HBCP
ARMP
Relative Strength Index (RSI) 56.22 39.00
Support Level $56.27 $5.14
Resistance Level $61.18 $8.40
Average True Range (ATR) 1.78 0.92
MACD 0.16 -0.48
Stochastic Oscillator 76.76 17.61

Price Performance

Historical Comparison
HBCP
ARMP

About HBCP Home Bancorp Inc.

Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities.It is holding company for Home Bank, N.A. The principal sources of funds are customer deposits, repayments of loans, repayments of investments, and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: